Axogen Appoints Lindsey Hartley as New CFO
Slice of Healthcare Team
May 13, 2025
Key Highlights
- New partnership aims to co-build multiple healthcare companies.
- Combines Redesign Health’s venture expertise with Cedars-Sinai’s clinical excellence.
- Focus on solving critical U.S. healthcare challenges.
- Access to Cedars-Sinai’s infrastructure and AI-ready datasets.
- Support for healthcare entrepreneurs with strategic funding and resources.
Source: Globe Newswire
Notable Quote
“ Nir joined the company at a time of significant leadership transition to provide leadership and stability to the finance function. I am delighted to announce the promotion of Lindsey Hartley to the role of Chief Financial Officer for Axogen. ”
Michael Dale, President, CEO, and Director at Axogen
“ I am honored to step into the CFO role at this pivotal moment for Axogen. ”
Lindsey Hartley, CFO at Axogen
Why This Matters
This executive leadership transition marks a critical phase in Axogen’s evolution as a key player in the peripheral nerve repair market. With a strong internal candidate like Lindsey Hartley assuming the CFO role, the company emphasizes continuity, strategic financial oversight, and growth-centric leadership. Hartley’s proven expertise in financial operations, compliance, and healthcare-specific accounting will be instrumental in guiding Axogen through its next strategic chapter as it expands its global footprint and continues to innovate in nerve restoration technologies.
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
